Joseph S. Takahashi is a Japanese American neurobiologist and geneticist. Takahashi is a professor at University of Texas Southwestern Medical Center as well as an investigator at the Howard Hughes Medical Institute. Takahashi's research group discovered the genetic basis for the circadian clock in 1994 and identified the CLOCK gene in 1997. Takahashi was elected to the National Academy of Sciences in 2003.
Takahashi was a postdoctoral fellow at the National Institute of Mental Health for two years under Martin Zatz before assuming a faculty position in Northwestern University's Department of Neurobiology and Physiology in 1983, where he held a 26-year tenure. Takahashi joined the faculty at the University of Texas Southwestern Medical Center at Dallas in 2008 as their Loyd B. Sands Distinguished Chair in Neuroscience. Takahashi also serves as a member of the Scientific Advisory Board of Hypnion Inc., a company focused on the development of novel therapeutics for central nervous system disorders affecting sleep and wake-alertness, as well as circadian rhythm abnormalities. He also serves as a member of the editorial boards of Neuron, Physiological Genomics and Journal of Biological Rhythms.
In 2010 Takahashi, Buhr, and Yoo examined the potential of temperature fluctuations to entrain biological oscillators. The finding that the master circadian pacemaker, a robust oscillator which is typically only entrained by environmental light/dark cycles, was also capable of entraining to temperature fluctuations when isolated in vitro indicates that temperature resetting is a fundamental property of all mammalian clocks and likely works through a highly conserved mechanism in all mammalian cells. This also suggests that body temperature rhythms, as controlled by the SCN in homeothermic mammals, is a potential mechanism through which the master clock may synchronize circadian oscillators within tissues throughout the body.
After the in vitro research on the pineal gland culture system used to understand circadian oscillations, the limitations of the cell culture system were evident and Takahashi switched methods to begin using forward genetics and positional cloning—tools which required no advanced knowledge of the underlying mechanism—to understand the genetic and molecular bases of circadian rhythms. Using mutated mouse strains, Takahashi and his colleagues isolated strains with abnormal period length and discovered the clock gene in 1994. They cloned the mammalian circadian clock gene in 1997.
In 2000, Takahashi made what he calls one of his most significant contributions to the field, which was the cloning of the mutant tau gene identified in 1988 by Menaker and Martin Ralph. Since its discovery in 1988, the tau gene had been studied thoroughly, however, due to limited genomic resources in hamsters, the organism in which it was discovered, a problem existed preventing further study. Through the use of a genetically directed representational difference analysis (GDRDA), the fragments of DNA that differed between the mutant and wild type hamsters. With this information, Takahashi then used positional syntenic cloning to identify synteny with the human genome. This revealed that the gene is closely related to the gene doubletime (dbt) in Drosophila, and casein kinase 1 epsilon (CKIe) in humans, both of which interact with and regulate PER levels.
In 2000, he and his colleagues at Northwestern recognized that clock mutant mice slept 1 to 2 hours less per night than wild type mice. Additionally, because these mice lack the circadian system that regulates consolidated sleep at a certain time of day, sleep in clock mutants is spread out throughout the day in both light-dark cycles and in complete darkness. This mutation results in less REM sleep and more time spent in earlier sleep phases.
In 2005, he collaborated with Joseph Bass and reported the effects of mutations in the clock gene on the metabolism and physiology of mice. Their experiments compared weight gain in Clock mutant mice to that of control mice and showed that mutant mice were more likely to gain weight. Such a discovery influenced them to pursue exploration of the clock gene's role in appetite and energy. In Clock mutant mice, they reported depressed levels of orexin, a neuropeptide involved in regulation of eating. This result provides further evidence that the clock gene has a profound impact on metabolic processes in mice.
It has since been discovered that metabolism itself plays a role in regulating the clock. In 2009, Joseph Bass in collaboration with Takahashi's group discovered that nicotinamide phosphoribosyltransferase (NAMPT) mediated synthesis of metabolic coenzyme nicotinamide adenine dinucleotide (NAD+), which both oscillate on a daily cycle, may play an important role in regulating circadian activity. By measuring the oscillations of NAMPT and NAD+ levels in the livers of both wild-type and mutant mice they determined that oscillations in NAMPT regulated NAD+ which in turn regulated the deacetylase SIRT1.
In 2007, Takahashi and his colleagues at Northwestern ran a ENU in mice looking for variations in circadian oscillations and subsequently identified a mutant which they named overtime ( Ovtm). Using positional cloning, genetic complementation, and in-situ hybridization Takahashi and colleagues discovered that Ovtm was a point mutation that caused a loss of function in FBXL3 – an F-box protein – and was expressed throughout the brain and in the SCN. Assaying expression of known circadian clock genes in the Ovtm mutants, they observed a marked decrease in PER1 and PER2 protein and mRNA levels in the brain and a significant decrease in cry2 mRNA levels only. Takahashi and his colleagues proposed that FBXL3 is a target site for protein degradation on the CRY2 protein, which would explain relatively normal CRY2 protein levels. Negative feedback by other elements of the circadian clock could then lead to the roughly 26-hour free-running period observed in Ovtm mice.
Continued mutagenesis studies
Awards and recognition
Notable papers
External links
|
|